Bradley Huth is an Oncology physician. OpenAlex indexes 729 publications with 371 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Medical Village Dr
Edgewood, KY 410173403
Telephone
859-301-2238Provider last certified this registry record 22 Jun 2022.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Galvanize Therapeutics, IncProgram year20251 payment
- Progenics Pharmaceuticals, Inc.Program year20231 payment
- Myovant Sciences Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
33.1%Opioid Agonist24.6%Oxycodone Hcl54%Oxycodone-Acetaminophen17%Morphine Sulfate17%Tramadol Hcl11%Part D<11 patientsBenzodiazepine4.8%Lorazepam100%Part D<11 patients+ 1 more class in this area
Cardiovascular
13%Antiarrhythmic13%Lidocaine Hcl Viscous100%Part D≥22 patientsMetabolism & gastrointestinal
12.3%Serotonin-3 Receptor Antagonist6.3%Ondansetron Hcl100%Part D≥15 patientsCorticosteroid3%Prednisone100%Part D≥12 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Scleral necrosis in patients with posterior uveal melanomas evaluated by transcleral fine needle aspiration biopsy and treated by 125I plaque
Arquivos Brasileiros de Oftalmologia
2018 - Lymphopenia as a predictor of survival in chemoradiation (CRT)-treated stage III non-small cell lung cancer (NSCLC).
Journal of Clinical Oncology
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”